Announced
Completed
Financials
Tags
Spain
Biotechnology
Venture Capital
biotechnology company
Acquisition
Minority
Single Bidder
Cross Border
Private
Private Equity
Completed
Friendly
Synopsis
Columbus Venture, a venture capital firm, led a €42m Series B round in Arthex Biotech, a biotechnology engineer, with the participation of the European Innovation Council fund, Hadean Ventures, Sound Bioventures, Invivo Capital, AdBio Partners, and CDTI. “EIT Health has helped Arthex develop and scale as a start-up company,” Beatriz Llamusí, Arthex Biotech CEO, CSO and Co-Founder.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.